COMMUNITY CONSULTATION: GLOBAL SCAN ON 'DECRIMINALISATION' POLICIES
Deadline: 30 October, 2020
To Apply: Send a CV, Letter of Interest and two writing samples to firstname.lastname@example.org
After half a century of global prohibition only a handful of countries have undertaken efforts towards the decriminalisation of drugs. Some countries purport to have moved towards decrim but have instead merely replaced one punitive system with another, either through diversion schemes, depenalisation or administrative penalties and sanctions which mandate rights-violating compulsory treatment or impose hefty fines. It is therefore vital that the various models confused with full decriminalisation are mapped out and that the voices, perspectives and experiences of people living under the legal and policy frameworks are elevated to better understand the real-life consequences of drug policy changes that are masquerading as, and being substituted for real change and progress on drug policy.
This consultancy aims to clearly articulate and delineate the differences between current models of decriminalisation from the perspective of people who use drugs. We are looking for an experienced researcher to take the task of mapping reforms and analyse them through the lens of drug user communities impacted by those reforms.
REGIONAL FOCUS POINTS (SIX REGIONS) - Development of INPUD - TBPeople joint position paper on TB among people who use drugs
In line with the Memorandum of Understanding, signed between INPUD and TBpeople, the two networks committed to “collaborate on raising the profile of the problem of TB among people who use drugs including the impact of prohibition and systematic discrimination of people who use drug to regard to the promotion of integrated people-centered services for people who use drugs and are affected by TB”. As a first step, the two networks agreed to develop a joint position paper on TB among people who use drugs, which will lay the foundation for future advocacy and programs.
To develop the position paper, a working group (WG) was established consisting of focal points of the two networks, acting as working group co-chairs, and up to eight members of the two networks from among people who use drugs and who are affected by TB (i.e. who have had TB or whose close one(s) had TB). The WG has produced a first draft of the joint position paper. To continue the work on the draft, TBpeople seeks to hire six regional focal points (RFPs), who will support the process of a global consultation by covering the following six regions: European Region (including Eastern Europe and Central Asia); Americas; Middle East and North Africa; Anglophone Africa; Francophone Africa; Asia and Pacific.